{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:27:47Z","timestamp":1762144067766},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1006\/taap.2002.9457","type":"journal-article","created":{"date-parts":[[2002,10,8]],"date-time":"2002-10-08T07:07:34Z","timestamp":1034060854000},"page":"41-45","source":"Crossref","is-referenced-by-count":27,"title":["Antiangiogenic Effect of a Highly Selective Cyclooxygenase-2 Inhibitor on Gastric Ulcer Healing in Rats"],"prefix":"10.1006","volume":"183","author":[{"given":"Jin Sheng","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi Hin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar Shiu","family":"Lam Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hau Tim","family":"Choy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Yao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel Wing","family":"Leung Koo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/taap.2002.9457_RF1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1006\/bbrc.1998.8436","article-title":"Nonsteriodal anti-inflammatory drugs may delay the repair of gastric mucosa by suppressing prostaglandin-mediated increase of hepatocyte growth factor production","volume":"245","author":"Bamba","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/taap.2002.9457_RF2","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis","volume":"343","author":"Bombardier","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/taap.2002.9457_RF3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1006\/taap.2002.9457_RF4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/jemt.1102","article-title":"Classic NSAID and selective cyclooxygenase COX-1 and COX-2 inhibitors in healing of chronic gastric ulcers","volume":"53","author":"Brzozowski","year":"2001","journal-title":"Microsc. Res. Tech."},{"key":"10.1006\/taap.2002.9457_RF5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0232-1513(82)80054-6","article-title":"Stimulation of wound healing, using brain extract with fibroblast growth factor (FGF) activity: II. Histological and morphometric examination of cells and capillaries","volume":"21","author":"Buntrock","year":"1982","journal-title":"Exp. Pathol."},{"key":"10.1006\/taap.2002.9457_RF6","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/1529-0131(200005)43:5<978::AID-ANR4>3.0.CO;2-0","article-title":"Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: Results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip","volume":"43","author":"Cannon","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1006\/taap.2002.9457_RF7","doi-asserted-by":"crossref","first-page":"6S","DOI":"10.1016\/S0002-9343(00)00681-1","article-title":"Efficacy of cyclooxygenase-2-specific inhibitors","volume":"110","author":"Cannon","year":"2001","journal-title":"Am. J. Med."},{"key":"10.1006\/taap.2002.9457_RF8","first-page":"551","article-title":"Rofecoxib [Vioxx, MK-0966, 4-[4\u2032-methysulfonylphenyl]-3-phenyl-2-(5H)-furanone]: A potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles","volume":"290","author":"Chan","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/taap.2002.9457_RF9","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1053\/gast.1997.v113.pm9322514","article-title":"The potentiating actions of cigarette smoking on ethanol-induced gastric mucosal damage in rats","volume":"113","author":"Chow","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1006\/taap.2002.9457_RF10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0223-5234(01)01197-7","article-title":"Cyclooxygenase inhibitors\u2014Current status and future prospects","volume":"36","author":"Dannhart","year":"2001","journal-title":"Eur. J. Med. Chem."},{"key":"10.1006\/taap.2002.9457_RF11","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1001\/archinte.160.12.1781","article-title":"A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis","volume":"160","author":"Day","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1006\/taap.2002.9457_RF12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3181\/00379727-172-41548","article-title":"PGE2 and angiogenesis","volume":"172","author":"Form","year":"1983","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1006\/taap.2002.9457_RF13","doi-asserted-by":"crossref","first-page":"18S","DOI":"10.1016\/S0002-9343(99)00364-2","article-title":"Pharmacology and efficacy of cyclooxygenase (COX) inhibitors","volume":"107","author":"Furst","year":"1999","journal-title":"Am. J. Med."},{"key":"10.1006\/taap.2002.9457_RF14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/gut.49.3.443","article-title":"Cyclooxygenase 2\u2014Implications on maintenance of gastric mucosal integrity and ulcer healing: Controversial issues and perspectives","volume":"49","author":"Halter","year":"2001","journal-title":"Gut"},{"key":"10.1006\/taap.2002.9457_RF15","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.37.5.610","article-title":"Basic fibroblast growth factor treatment for non-steroidal anti-inflammatory drug associated gastric ulceration","volume":"37","author":"Hull","year":"1995","journal-title":"Gut"},{"key":"10.1006\/taap.2002.9457_RF16","first-page":"767","article-title":"Expression of fibroblast growth factor-2 transcripts in the healing of acetic acid-induced gastric ulcers","volume":"107","author":"Kimura","year":"1999","journal-title":"A. P. M. I. S."},{"key":"10.1006\/taap.2002.9457_RF17","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/gut.34.7.881","article-title":"Fibroblast growth factor in gastroprotection and ulcer healing: Interaction with sucralfate","volume":"34","author":"Konturek","year":"1993","journal-title":"Gut"},{"key":"10.1006\/taap.2002.9457_RF18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1254\/jjp.75.105","article-title":"Significant roles of inducible cyclooxygenase (COX-2) in angiogenesis in rat sponge implants","volume":"75","author":"Majima","year":"1997","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1006\/taap.2002.9457_RF19","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0149-2918(99)80045-9","article-title":"Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: A randomized, placebo- and active-comparator-controlled clinical trial","volume":"21","author":"Malmstrom","year":"1999","journal-title":"Clin. Ther."},{"key":"10.1006\/taap.2002.9457_RF20","first-page":"1306","article-title":"Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors","volume":"60","author":"Masferrer","year":"2000","journal-title":"Cancer Res."},{"key":"10.1006\/taap.2002.9457_RF21","first-page":"504","article-title":"Rofecoxib, a specific cyclooxygenase-2 inhibitor, in primary dysmenorrhea: A randomized controlled trial","volume":"94","author":"Morrison","year":"1999","journal-title":"Obstet. Gynecol."},{"key":"10.1006\/taap.2002.9457_RF22","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1046\/j.1365-2036.1999.00627.x","article-title":"Effect of basic fibroblast growth factor on gastric ulcer healing and its own mRNA expression","volume":"13","author":"Pohle","year":"1999","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1006\/taap.2002.9457_RF23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1254\/jjp.73.59","article-title":"Role of endogenous basic fibroblast factor in the healing of gastric ulcers in rats","volume":"73","author":"Satoh","year":"1997","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1006\/taap.2002.9457_RF24","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sj.bjp.0701672","article-title":"Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastrointestinal ulcer models in rats","volume":"123","author":"Schmassmann","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1006\/taap.2002.9457_RF25","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/S0149-2918(99)80048-4","article-title":"The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis","volume":"21","author":"Schnitzer","year":"1999","journal-title":"Clin. Ther."},{"key":"10.1006\/taap.2002.9457_RF26","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/325257a0","article-title":"Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth","volume":"325","author":"Schweigerer","year":"1987","journal-title":"Nature"},{"key":"10.1006\/taap.2002.9457_RF27","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/gut.47.4.527","article-title":"COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: A double blind crossover study comparing rofecoxib with placebo and indomethacin","volume":"47","author":"Sigthorsson","year":"2000","journal-title":"Gut"},{"key":"10.1006\/taap.2002.9457_RF28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1365-2036.2001.00889.x","article-title":"Up-regulation of cyclooxygenase-1 and -2 in human gastric ulcer","volume":"15","author":"To","year":"2001","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1006\/taap.2002.9457_RF29","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1111\/j.1440-1746.1994.tb01304.x","article-title":"Validity of kissing gastric ulcers induced in rats for screening of antiulcer drugs","volume":"9","author":"Tsukimi","year":"1994","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1006\/taap.2002.9457_RF30","doi-asserted-by":"crossref","first-page":"19S","DOI":"10.1016\/S0002-9343(00)00631-8","article-title":"Machanisms of protection and healing: Current knowledge and future research","volume":"110","author":"Wallace","year":"2001","journal-title":"Am. J. Med."},{"key":"10.1006\/taap.2002.9457_RF31","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0149-2918(01)80112-0","article-title":"Rofecoxib: Clinical pharmacology and clinical experience","volume":"23","author":"Weaver","year":"2001","journal-title":"Clin. Ther."},{"key":"10.1006\/taap.2002.9457_RF32","first-page":"475","article-title":"Role of prostaglandin E1 and copper in angiogenesis","volume":"69","author":"Ziche","year":"1982","journal-title":"J. Natl. Cancer Inst."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X02994573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X02994573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T19:16:40Z","timestamp":1547579800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X02994573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["S0041008X02994573"],"URL":"https:\/\/doi.org\/10.1006\/taap.2002.9457","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2002,8]]}}}